A phase IIIB, randomized, controlled, observer-blind study to evaluate safety and immunogenicity of GSK’s meningococcal ABCWY vaccine when administered in healthy adolescents and adults, previously primed with meningococcal ACWY vaccine

  • Carr, Jeremy (Primary Chief Investigator (PCI))

Project: Research

Project Details

Effective start/end date8/07/217/07/26


  • clinical trial
  • phase 3 study
  • treatment efficacy
  • vaccine safety
  • vaccine efficacy
  • meningococcal